Table 1.
Baseline characteristics of participants
| Variable | Placebo | HL301 | All | p value |
|---|---|---|---|---|
| Number (FAS) | 85 | 81 | 166 | |
| Sex, male:female | 45:40 | 47:34 | 92:74 | 0.51 |
| Age, yr | 38.53 ± 10.93 | 35.99 ± 11.71 | 37.29 ± 11.35 | 0.15 |
| Heavy smokera | 0 | 0 | 0 | NA |
| Comorbidities | 32 (37.65) | 25 (30.86) | 57 (34.34) | 0.35 |
| Respiratory | 10 | 7 | 17 | |
| Infection | 6 | 10 | 16 | |
| Metabolic | 5 | 9 | 14 | |
| Musculoskeletal | 7 | 4 | 11 | |
| Gastrointestinal | 7 | 3 | 10 | |
| Vascular | 3 | 7 | 10 | |
| Dermatologic | 5 | 4 | 9 | |
| Others | 24 | 14 | 38 |
Values are presented as mean ± SD or number (%).
FAS, full analysis set; NA, not available.
a
Those who smoke > 15 cigarettes/day.